These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 2508125

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Cyclooxygenase and lipoxygenase pathways in anterior uvea and conjunctiva.
    Kulkarni PS, Srinivasan BD.
    Prog Clin Biol Res; 1989; 312():39-52. PubMed ID: 2508129
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. External ocular inflammatory effects of lipoxygenase enzyme products.
    Napoli SA, Helm C, Insler MS, Ensley HE, Pretus HA, Feigen LP.
    Ann Ophthalmol; 1990 Jan; 22(1):30-4. PubMed ID: 2155571
    [Abstract] [Full Text] [Related]

  • 7. Dual stimulation of phospholipase activity in human monocytes. Role of calcium-dependent and calcium-independent pathways in arachidonic acid release and eicosanoid formation.
    Hoffman T, Lizzio EF, Suissa J, Rotrosen D, Sullivan JA, Mandell GL, Bonvini E.
    J Immunol; 1988 Jun 01; 140(11):3912-8. PubMed ID: 2836505
    [Abstract] [Full Text] [Related]

  • 8. The ocular effects of eicosanoids and other autacoids: historic background and the need for a broader perspective.
    Stjernschantz J, Bito LZ.
    Prog Clin Biol Res; 1989 Jun 01; 312():1-13. PubMed ID: 2571999
    [Abstract] [Full Text] [Related]

  • 9. The synthesis and effects of eicosanoids in avascular ocular tissues.
    Bazan HE.
    Prog Clin Biol Res; 1989 Jun 01; 312():73-84. PubMed ID: 2508131
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Prostaglandins and inflammatory reactions in the eye.
    Bhattacherjee P.
    Methods Find Exp Clin Pharmacol; 1980 Feb 01; 2(1):17-31. PubMed ID: 6803089
    [Abstract] [Full Text] [Related]

  • 17. Role of leukotrienes and lipoxygenases in glomerular injury.
    Nassar GM, Badr KF.
    Miner Electrolyte Metab; 1995 Feb 01; 21(4-5):262-70. PubMed ID: 7565475
    [Abstract] [Full Text] [Related]

  • 18. Lipid inflammatory mediators in diabetic vascular disease.
    Natarajan R, Nadler JL.
    Arterioscler Thromb Vasc Biol; 2004 Sep 01; 24(9):1542-8. PubMed ID: 15166011
    [Abstract] [Full Text] [Related]

  • 19. [Pharmacology of the leukotrienes].
    Sirois P, Borgeat P.
    J Pharmacol; 1984 Sep 01; 15 Suppl 1():53-68. PubMed ID: 6328128
    [Abstract] [Full Text] [Related]

  • 20. Involvement of cyclooxygenase-2 in rat models of conjunctivitis.
    Oka T, Shearer T, Azuma M.
    Curr Eye Res; 2004 Jul 01; 29(1):27-34. PubMed ID: 15370364
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.